Show
Sort by
-
- Journal Article
- A1
- open access
Evaluation of an epigenetic assay for predicting repeat prostate biopsy outcome in African American men
-
A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients
-
Evaluation of different methods to assess homologous recombination status and sensitivity to PARP inhibitors in ovarian cancer
-
CD44 and OTP are strong prognostic markers for pulmonary carcinoids
-
Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study